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Background: Different interventions are offered to children with cerebral palsy
(CP) to improve the activity domain of the international classification of functioning
(ICF). In therapy settings, the focus is mostly on motor capacity, but the ultimate goal
is to improve motor performance. We therefore examined if changes in motor capac-
ity outcomes are accompanied by changes in objectively measured motor perfor-
mance after a 3‐month intensive treatment period in ambulatory children with CP.
Methods: A secondary analysis on prospective clinical trial data was performed using
multivariate linear regression. Sixty‐five children (37 boys and 28 girls) with spastic CP,
mean age 7 years and 3 months, Gross Motor Function Classification System (GMFCS)
levels I–III were involved in a distinct 3‐month intensive treatment period.Motor capac-
ity (Gross Motor Function Measure [GMFM], functional muscle strength [FMS], and
walking speed [WS]) and motor performance (using three Actigraph‐GT3X+‐derived
outcome measures) were measured at baseline, 12 and 24 weeks.
Results: No significant associations were found for any of the change scores (Δ12)
between motor capacity and motor performance after a 12‐week intensive treatment
period. After 24 weeks, Δ24FMS (p = .042) and Δ24WS (p = .036) were significantly
associated with changes in motor performance outcome measure percentage of time
spent sedentary (Δ24%sedentary). In this model, 16% of variance of Δ24%sedentary
was explained by changes in motor capacity (p = .030).
Conclusions: Changes in motor capacity are mostly not accompanied by changes in
objectively measured motor performance after an intensive treatment period for
ambulatory children with CP. These findings should be taken into account during goal
setting and are important to manage expectations of both short‐ and longer term
effects of treatment programmes.- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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• Changes in motor capacity outcomes are mostly not
accompanied by changes in actual motor performance
after one distinct intensive treatment period.
• The lack of a clear longitudinal capacity–performance
relationship should be taken into account during goal
setting and expectation management in treatment of
individual patients.
• Future treatment programmes should focus more
specifically on motor performance next to motor capacity.
• Other factors than just motor capacity (such as social and
environmental opportunities) should be taken into
account to achieve an improvement in motor performance.1 | INTRODUCTION
Cerebral palsy (CP) is a disorder of development of movement and
posture with a wide variety of consequences in different domains of
functioning such as physical behaviour, sensation, perception, commu-
nication, cognition, and behaviour (Rosenbaum et al., 2007). Children
with CP are not only heterogeneous in their level of functioning in
these domains but also in aetiology, presentation, comorbidities, and
response to treatment (Shevell, 2018).
Different interventions are offered to improve the level of func-
tioning in children with CP (Novak et al., 2013; Ryan, Cassidy,
Noorduyn, & O'Connell, 2017). The effectiveness of these interven-
tions for childhood CP can be assessed on different levels of the
World Health Organization's international classification of functioning
(ICF) (World Health Organization, 2001). Although all ICF levels are
important in ambulatory children with CP in their primary school
age, the activity level, with its classifiers capacity (what children can
do in a standardized environment) and performance (what children
actually do in daily life) (World Health Organization, 2001), are of spe-
cial interest (Holsbeeke, Ketelaar, Schoemaker, & Gorter, 2009; Novak
et al., 2013; Ryan et al., 2017). Optimizing performance is, however,
the ultimate goal for children with CP in order to keep up at school,
come along with their friends, and participate in other daily activities.
From the perspective of motor functioning, several outcome
measures can be used to assess capacity and performance. Of the
presently available outcome measures for motor capacity in CP, the
valid Gross Motor Function Measure (GMFM) can be considered as
the “gold” standard (Harvey, Robin, Morris, Graham, & Baker, 2008).
Motor performance can be assessed with self‐reported methods (such
as questionnaires) or objective techniques (such as activity monitors).
Accelerometry‐based activity monitors have shown good reliability
and validity for measuring physical behaviour in children with CP
and are therefore the preferred method to assess motor performance
(Mitchell, Ziviani, & Boyd, 2015; O'Neil et al., 2016).
Most children with CP get lifelong therapies in which becoming
less sedentary and more active (i.e. improving motor performance) is
a common treatment goal, in particular for the ambulatory subgroup
in their primary school age. However, during a treatment period, the
focus is mostly on motor capacity, for which the GMFM is routinely
used, and not on motor performance. The reason for this might be that
most of the time activity monitor measurements are not feasible or
that experience is lacking to perform such measurements. Another
reason might be that in daily practice, it is often reasoned that
improvements in actual motor performance can be achieved and
assessed indirectly by improvements in motor capacity.
From a clinical viewpoint, it is especially important to check this
assumption and to determine if an intervention‐related change in motor
capacity is actually accompanied by a change towards a more optimalmotor performance. So far, only few studies studied this “capacity–
performance relationship” longitudinally (Ho, Chang, Granlund, &Hwang,
2017; Smits et al., 2014; van Eck, Dallmeijer, Voorman, & Becher, 2009;
Wright et al., 2008). Significant relationships were found in three studies,
but these relationships showed to be highly variable (Ho et al., 2017;
Smits et al., 2014; van Eck et al., 2009). Only the study of Wright et al.
(2008) was in the context of one delineated intensive treatment period
and showedmainly nonsignificant change score relationships. It is impor-
tant to note that in all studies, motor performance was not assessed
objectively, but with self‐reported outcome measures.
To our knowledge, no study so far has longitudinally described the
capacity–performance relationship in the context of one distinct
intensive treatment period in children with CP, using an objective per-
formance outcome measure that represents what the children actually
do in daily life. To better guide treatment for individuals with CP, we
examined if changes in motor capacity outcomes are accompanied
by a change in objectively measured motor performance immediately
after a 3‐month intensive treatment period in ambulatory children
with CP, and 3 months thereafter.2 | METHODS
2.1 | Design and participants
A secondary analysis on prospective clinical trial data was performed,
using the dataset from the Dutch SPACE BOP study (“SPAstic cerebral
palsy; Cost‐Effectiveness of BOtulinum toxin and Physiotherapy”,
inclusion period: October 2009 to September 2013) (Schasfoort,
Dallmeijer, et al., 2018; Schasfoort, Pangalila, et al., 2018). The primary
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combinedwith comprehensive rehabilitationwith comprehensive reha-
bilitation alone. The SPACE BOP study was a pragmatically designed,
single‐blind, multicentre trial. The study was not fully randomized: Ran-
domized participants and those who had objections to randomization
(because they strongly preferred one of the interventions) were both
enrolled in the study. Initially, all parents of eligible children were
invited to participate on a randomized basis. Randomization was
stratified by Gross Motor Function Classification System (GMFCS)
level. If parents declined randomization, they could participate in the
treatment group of their preference. Physiotherapists, outcome
assessors, and data analysts were blinded for both randomized and
not‐randomized participants. Randomized participants were blinded
until after baseline measurements. Power calculations showed that a
sample size of 60 children was sufficient (Schasfoort, Dallmeijer, et al.,
2018). The power of this secondary analysis was considered sufficient
considering the general rule of 10 to 15 participants per variable.
In total, 65 children 4–12 years of age with a diagnosis of spastic
CP with primarily lower extremity involvement (unilateral or bilateral),
GMFCS levels I–III, and an indication for botulinum toxin treatment
were included in the study (40% participated with randomization).
Botulinum toxin treatment <6 months or CP‐related surgery <12
months at enrolment, being cognitively unable to understand instruc-
tions, presence of contractures or severe comorbidity were reasons
for exclusion. Children were recruited from two university hospitals
and five rehabilitation centres in the Netherlands. The study was
approved by the ethics committee of Erasmus MC and written
informed consent was obtained from parents/primary caregivers.2.2 | Procedures
For the present analysis, we used the data of the 65 included children
as one group. All children followed a period of 12 weeks of intensive
functional physiotherapy (ideally three 45‐ to 60‐minute sessions each
week) with the purpose to improve motor capacity and motor perfor-
mance. A subgroup of children received botulinum toxin 1 week prior
to the start of the physiotherapy period. If indicated by the spasticity
management team, children got 2–4 weeks of serial casting (1 week
after physiotherapy had started) and/or new or realignment of ankle
foot orthoses (AFOs), as soon as possible. All children (independent
of whether they received botulinum toxin or not) could be considered
for these additional treatments. The motor capacity and performance
outcome measures were measured at baseline, 12 weeks (primary
endpoint and end of the intensive treatment period) and 24 weeks.2.3 | Outcome measures
Motor capacity was assessed using three outcome measures: gross
motor function (GMFM), functional muscle strength (FMS), and walking
speed (WS). We used the Gross Motor Function Measure 66 Item Set
version (GMFM66‐IS) to measure gross motor function. Russell et al.
(2010) have shown that this short version of the GMFM‐66 is a validand reliable method for children with CP. A difference of 0.8 on the
overall GMFM‐66 score is considered a minimum clinically important
difference (Oeffinger et al., 2008). FMS was measured by the
30‐seconds sit‐to‐stand test (STS); this involves the maximum number
of sit‐to‐stands in 30 seconds. This test has shown good reliability
and moderate validity for children with CP (Chrysagis, Skordilis, &
Koutsouki, 2014). WS (in m/s), at a comfortable pace with shoes and,
if applicable, AFOs, was measured during a two‐dimensional (2D)
instrumented gait analysis on a 10 meter walkway. WS was calculated
using the sagittal spatiotemporal information of the lateral malleolus
from the 2D space calibrated middle 3 meter of the walkway.
Motor performance, comprising both physical activity and sedentary
behaviour (Bussmann & van den Berg‐Emons, 2013), was measured
objectively by the Actigraph activity monitor (Actigraph‐GT3X+).
This device has been widely validated for measuring daily activity in
children with CP (Mitchell et al., 2015; O'Neil et al., 2016). All children
were asked to wear the Actigraph for 7 days. Children had to wear the
device for at least 480 minutes (8 hours) during daytime; the data for
days with shorter weartime were excluded from the analysis. When
swimming, bathing/showering, or sleeping the Actigraph was taken
off. ActiLife software (version 6.6.2) was used to analyse the Actigraph
signals. Based on the three axes, a vector magnitude was calculated. A
period of zero counts for 15 minutes or longer was considered as a
nonwear period. Average intensity of physical activity counts per min-
ute (CPM) for “all day” and “after school” (defined as the time after 2
p.m. on weekdays and full weekend days) and average percentage of
the day spent sedentary (%sedentary) were calculated. Evenson cut‐
off points (based on the vertical axis) were used to define %sedentary
(0–25 counts per 15 seconds) (Evenson, Catellier, Gill, Ondrak, &
McMurray, 2008).We calculated the CPM for both the all day and after
school period becausewe assumed that children have less opportunities
for actual performance of physical activities at school compared with
their time after school.2.4 | Statistical analysis
Descriptive statistics were used to provide an overview of patient
characteristics and to calculate mean (SD) scores. From here, change
scores were calculated (12 weeks—baseline [Δ12] and 24 weeks—
baseline [Δ24]) for all outcome measures. It is important to look at
change scores at both 12 and 24 weeks because a change in motor
performance generally takes time. Paired T tests were used to assess
if motor capacity and motor performance outcome measures changed
significantly after 12 and 24 weeks and to determine differences
between ΔCPM all day and ΔCPM after school.
Subsequently, blockwise multivariate linear regression analyses
were performed to investigate if changes in motor capacity were
associated with changes in motor performance, and to determine the
relative contribution of changes in motor capacity outcome measures
and child characteristics to (variance of) changes in motor performance
outcome measures. Motor performance change scores after 12 and 24
weeks (ΔCPM all day, ΔCPM after school, and Δ%sedentary) were
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performed separate analyses for the data after 12 and 24 weeks using
identical blocks. In the first block, motor capacity change scores
(ΔGMFM, ΔFMS, and ΔWS), respectively after 12 and 24 weeks, were
entered as independent variables. GMFCS level and age were added
to the model in the second block. Finally, we created scatterplots to
see if the longitudinal capacity–performance relationship differed for
GMFCS levels. P values below .05 were considered statistically
significant. SPSS 22.0 and 25.0 were used for all statistical analyses.3 | RESULTS
A total of 65 children were enrolled in the SPACE BOP study. Baseline
characteristics are outlined in Table 1. The study population had a
mean age of 7 years and 3 months, and more boys than girls were
included. Children were equally distributed across GMFCS Levels I,
II, and III, and most children had the bilateral type of CP. Everyone
received intensive physiotherapy for a period of 12 weeks, and 41
children were treated with botulinum toxin prior to comprehensive
rehabilitation. Additional interventions during this period were casting
(32 children) or new/realigned AFOs (21 children), of whom 15 chil-
dren had both casting and AFOs.
Outcomes at baseline and change scores after 12 (Δ12) and 24
weeks (Δ24) from baseline are outlined in Table 2. Overall, statistically
significant changes were found for motor capacity outcome measures
after 12 and 24 weeks, in contrast to the motor performance outcome
measures. There were no significant differences in improvement of
CPM after school compared with CPM all day (35 vs. 18 CPM after
12 weeks, P = .23, and 56 vs. 30 CPM after 24 weeks, P = .10).TABLE 1 Patient characteristics at baseline, n = 65
Patient characteristics n (%)
Mean age in years
and months (SD)
7 years and 3 months
(2 years and 4 months)
Gender
Boy 37 (57%)
Girl 28 (43%)
GMFCS
Level I 19 (29%)
Level II 23 (35%)
Level III 23 (35%)
CP type
Unilateral 14 (22%)
Bilateral 51 (78%)
Treatment with botulinum toxin 41 (63%)
Casting period (unilateral or bilateral) 32 (49%)
New/realignment AFOs 21 (32%)
Abbreviations: AFOs, ankle foot orthoses; CP, cerebral palsy; GMFCS,
Gross Motor Function Classification System.Results from blockwise multivariate linear regression analyses,
with motor performance change scores after 12 and 24 weeks as
dependent variables, are presented in Tables 3 and 4, respectively.
After 12 weeks, changes in motor capacity outcomes were not signif-
icantly associated with changes in motor performance outcomes
(Block 1), and the child characteristics (age and GMFCS level) also
did not contribute significantly to changes in motor performance out-
comes (Block 2). The total explained percentage of variance of both
blocks was low (ranged from 1% to 6%) and not statistically significant.
After 24 weeks, Δ24FMS and Δ24WS showed significant negative
associations with Δ24%sedentary in Blocks 1 and 2 (P = .036 to P =
.042): Improvements in FMS and WS were associated with a decrease
in %sedentary. Only for the dependent variable Δ24%sedentary the
model in Block 1 was statistically significant, with a total explained
percentage of variance of 16% (P = .030). The capacity–performance
relationship for GMFM with CPM all day after 12 weeks did not differ
for differently GMFCS levels (Figure 1). This was also the case for all
other relationships between changes in motor capacity and motor per-
formance after 12 weeks (not presented as figure).4 | DISCUSSION
We found that changes in motor capacity were mostly not accompa-
nied by changes in motor performance in ambulatory children with
CP within the context of one distinct intensive treatment period.
The few associations that were found, might indicate that the relation-
ship between changes in motor capacity and motor performance
depends on measurement interval and type of motor capacity and per-
formance outcome measure. In the end, only one model was statisti-
cally significant with a total explained percentage of variance of
16%, suggesting that multiple other factors play a role in the
capacity–performance relationship.
Our findings are generally in line with a previous study (Wright
et al., 2008), although they mainly looked at relationships between
changes in outcomes covering different domains of the ICF (body
functions and structures, activities, and participation). In contrast, we
specifically focused on the relationship between changes in motor
capacity and motor performance within the ICF activity domain. Dif-
ferent to our results, other colleagues found stronger evidence of sig-
nificant associations between changes in motor capacity and motor
performance (Ho et al., 2017; Smits et al., 2014; van Eck et al.,
2009; Wright et al., 2008). The populations in these studies differed
somewhat from our population: They all included children with, pre-
dominantly spastic, CP from all GMFCS levels (Ho et al., 2017; Smits
et al., 2014; van Eck et al., 2009) (vs. children with spastic CP, GMFCS
levels I–III in our study), and two studies had a study population that
was slightly older (Ho et al., 2017; van Eck et al., 2009). The most
important differences, however, are follow‐up period (1–3 years vs.
3–6 months in our study), the fact that we looked at results of one dis-
tinct treatment period (vs. “natural” development of motor capacity
and motor performance), and the use of self‐reported vs. objective
outcome measures for motor performance in our study. Maybe,
TABLE 2 Baseline scores and change scores after 12 and 24 weeks for motor capacity and performance outcome measures
Baseline Change score after 12 weeks (Δ12) Change score after 24 weeks (Δ24)
Mean (SD) Range N Mean (SD) (%) Range N P Mean (SD) (%) Range N P
Weartime in days 6.1 (1.2) 5.5 (1.4)a 5.4 (1.6)b
Motor capacity
GMFM (score) 68.5 (12.7) 43.0–92.1 65 1.0 (2.5) 1.5 −6.4–7.4 65 .002* 2.0 (3.3) 2.9 −9.8–9.1 65 <.001*
FMS (number STS) 12.8 (3.7) 5.0–23.0 65 1.1 (2.9) 8.9 −6–10 65 .003* 1.3 (2.9) 10 −7–9 65 <.001*
Walking speed with
shoes/AFOs (m/s)
0.90 (0.27) 0.39–1.60 62 0.01 (0.24) 0.7 −0.61–0.55 60 .847 0.11 (0.25) 12 −0.55–0.78 60 .001*
Motor performance
CPM all day (counts) 819 (321) 310–1701 65 18 (200) 2.2 −565–464 61 .477 30 (173) 3.7 −469–429 60 .185
CPM after school (counts) 850 (353) 212–1757 65 35 (262) 4.1 −583–718 61 .307 56 (236) 6.6 −486–937 60 .07
% Sedentary (%) 72.1 (8.6) 40.8–87.3 65 −0.7 (5.3) −1.0 −15.1–14.8 61 .295 −0.4 (4.6) −0.6 −9.8–9.1 60 .476
Abbreviations: AFOs, ankle foot orthoses; CPM, counts per minute; FMS, functional muscle strength; GMFM, Gross Motor Function Measure; STS, sit‐to‐
stand test. The bold entries are used to highlight the statistical significant results
aMean weartime in days at 12 weeks (SD).
bMean weartime in days at 24 weeks (SD).
*P < .05.
TABLE 3 Blockwise multiple regression analyses for changes in three performance outcome measures with capacity change scores and patient
characteristics (age, GMFCS) as independent variables (0–12 weeks)
Multiple regression with 0–12 weeks change
scores for performance outcomes as dependent
Δ12CPM all day (n = 56) Δ12CPM after school (n = 56) Δ12%Sedentary (n = 56)
Β P β P Β P
Block 1: capacity change scores 0–12 weeks
Δ12GMFM (score) −3.4 .766 5.3 0.726 −0.03 .907
Δ12FMS (number STS) 6.0 .525 14.0 0.259 −0.4 .126
Δ12Walking speed with shoes/AFOs (m/s) −40.1 .736 −75.2 0.627 2.1 .497
R2 total 0.01 .902 0.04 0.573 0.06 .362
Block 2: capacity change scores 0–12 weeks, adjusted for age and GMFCS level
Δ12GMFM (score) −3.1 .801 8.4 0.593 −0.1 .877
Δ12FMS (number STS) 6.1 .528 14.7 0.241 −0.4 .131
Δ12Walking speed with shoes/AFOs (m/s) −42.0 .731 −92.1 0.559 2.2 .475
Age (in years) 1.2 .922 9.9 0.544 −0.01 .967
GMFCS levels (I–III) −5.0 .895 −43.2 0.372 0.4 .698
R2 change 0.00 .989 0.02 0.620 0.003 .925
R2 total 0.01 .989 0.06 0.708 0.06 .654
Abbreviations: AFOs, ankle foot orthoses; CPM, counts per minute; FMS, functional muscle strength; GMFM, Gross Motor Function Measure; STS, sit‐to‐
stand test.
*P < .05.
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our study had longer follow‐up time, especially considering that
achieving changes in motor performance may take time. Other studies
mainly looked at associations between changes in motor capacity and
motor performance in children's (natural) development over time, but
we do not know the intensity of their therapies and to what degree
these children were involved in interventions. Another important dif-
ference is that we know that self‐reported outcome measures differfrom objective outcome measures and are more susceptible to recall
and social desirability bias (Adamo et al., 2009; Prince et al., 2008).
We therefore believe that measuring motor performance objectively
with activity monitors (for a few days) gives a more valid representa-
tion of intervention‐related changes in what children actually do dur-
ing their daily life.
The finding that motor capacity changes (Δ24FMS andΔ24WS) were
only significantly associated with changes in the motor performance
TABLE 4 Blockwise multiple regression analyses for changes in three performance outcome measures with capacity change scores and patient
characteristics (age, GMFCS) as independent variables (0–24 weeks)
Multiple regression with 0–24 weeks change
scores for performance outcomes as dependent
Δ24CPM all day (n = 55) Δ24CPM after school (n = 55) Δ24%Sedentary (n = 55)
Β P β P β P
Block 1: capacity change scores 0–24 weeks
Δ24GMFM (score) 0.1 .993 4.5 .668 −0.01 .972
Δ24FMS (number STS) 8.8 .314 14.6 .220 −0.5 .042*
Δ24Walking speed with shoes/AFOs (m/s) 156.1 .102 208.4 .107 −5.0 .036*
R2 total 0.07 .285 0.09 .168 0.16 .030*
Block 2: capacity change scores 0–24 weeks, adjusted for age and GMFCS level
Δ24GMFM (score) 0.3 .973 3.2 .763 0.01 .959
Δ24FMS (number STS) 8.4 .363 17.4 .161 −0.5 .036*
Δ24Walking speed with shoes/AFOs (m/s) 157.3 .123 218.4 .111 −5.3 .039*
Age (in years) −1.3 .907 11.0 .457 −0.2 .536
GMFCS levels (I–III) 8.0 .805 −32.7 .455 0.3 .722
R2 change 0.00 .967 0.02 .637 0.01 .801
R2 total 0.07 .581 0.11 .314 0.17 .101
Abbreviations: AFOs, ankle foot orthoses; CPM, counts per minute; GMFM, Gross Motor Function Measure; FMS, functional muscle strength; STS, sit‐to‐
stand test.
*P < .05.
FIGURE 1 Illustrative scatterplots for the associations between GMFM and CPM all day change scores between baseline and 12 weeks for
GMFCS levels I–III. CPM, counts per minute; GMFM, Gross Motor Function Measure
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Δ24CPM after school, confirms that sedentary behaviour indeed is a
different and independent construct of motor performance (Bussmann
& van den Berg‐Emons, 2013). Also, our results seem to support the
assumption that changing motor performance generally takes time.
Only few significant associations between changes in motor capac-
ity and motor performance were found. Regarding the interpretation
of findings from our analyses, it is important to realize that results
depend on the effects and effect sizes of the intervention that children
received. In our case, motor performance outcomes showed small non-
significant changes after a period of intensive treatment. This finding is
not strange, because maintaining the level of functioning is often con-
sidered an important treatment goal in chronic rehabilitation popula-
tions such as CP. Moreover, longitudinal developmental trajectories
of physical activity for children with CP have shown a decrease overtime in the amount and intensity of physical activity in a group similar
to the presently studied ambulatory age group (Bjornson et al., 2019).
This should be taken into account together with the large variation in
motor performance in general (Bjornson et al., 2019) and the heteroge-
neity that is inherent to CP (Damiano, 2014; Shevell, 2018).
The lack of a clear association between changes in motor capac-
ity and changes in (especially the physical activity part of) motor per-
formance after an intensive treatment period raises the question if
we should change the way of treatment or add other components
to treatment focusing more on performance and individual treatment
goals. This is supported by Novak et al. (2013) who showed that
interventions work on no more than one level of the ICF. Bjornson,
Zhou, Stevenson, and Christakis (2013) already suggested interven-
tions focusing on motor performance instead of motor capacity.
And more recently, Reedman, Boyd, and Sakzewski (2017) found a
72 HALMA ET AL.modest (but clinically insufficient) effect of therapy and behaviour
change interventions on motor performance (as measured by activity
monitors) in a systematic review. The limited environmental and
social possibilities of children with CP may also play a role, and
maybe we should focus more on creating these possibilities. We
think that one of the most important factors is the (school)pro-
gramme children have to follow during the day. Despite the fact that
our data showed no statistically significant difference between
change scores of CPM all day and CPM after school, we still con-
sider the finding that children are more active in the after school
period of important clinical relevance. Our assumption is also sup-
ported by previous studies in healthy children showing that children
spent less time sedentary and more time active in the after school
period (Arundell, Hinkley, Veitch, & Salmon, 2015; Verloigne et al.,
2017). Therefore, maybe we should incorporate more activities in
the (school)programme of children with CP and break up long
periods of sedentary time during the day.
Some limitations should be considered. First, general limitations
known to ambulatory monitoring techniques, such as compliance in
wearing time, inability to measure activities involving water, and
seasonal influences, should be taken into account. Because motor per-
formance varies during the day and between days, we cannot fully
guarantee that individual Actigraph measurements were gathered on
representative days. However, this factor is minimalized by a mean
wearing time of 6 days (of at least 8 hours a day). Second, we like to
address the possible ceiling effect of the GMFM. This may have
played a role but is a general issue known to the population of
ambulatory children with CP. Despite this, the GMFM remains the
gold standard to measure motor capacity, and we did find statistically
significant and clinically relevant improvements in GMFM scores
(Harvey et al., 2008). Finally, our data were limited to measurements
after 12 and 24 weeks in a relative small group of 65 ambulatory
children with CP. It would have been interesting to study the
capacity–performance relationship in a larger group, after a longer
follow‐up period, and also take personal and environmental barriers
and facilitators into account (Bloemen et al., 2015).
In conclusion, we found that changes in motor capacity are mostly
not accompanied by changes in objectively measured motor perfor-
mance. Type of outcome measures, measurement interval, and multi-
ple other factors seem to be of influence. Clinicians and parents
should be aware of this so these findings can be taken into account
during goal setting and management of expectations of the effects
of (intensive) treatment programmes. Because of the lack of a clear
longitudinal capacity–performance relationship, it is important to eval-
uate our current treatment programmes that are mainly focused on
improving motor capacity and less on improving motor performance.
Incorporating interventions more specifically focusing on improving
motor performance into current treatment programmes (based on
individual patient goals and needs), creating social and environmental
opportunities to optimize the use of motor capacity in daily life and
evaluation of normal day to day programmes of children with CP prob-
ably is a good starting point in reaching long‐term improvement in
both motor capacity and motor performance.ACKNOWLEDGEMENTS
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